BioVaxys Announces 96.4 Percent Positive Antibody Immune Response Results from an In Vivo Murine Model Study of Its SARS-CoV-2 Vaccine BioVaxys Technology Corp. Nov 11, 2020 17:00 HKT/SGT Read More
エーザイとMSD、「レンビマ(R)」と「キイトルーダ(R)」の併用療法が進行性腎細胞がんを対象とした一次療法において統計学的に有意な改善を示す Eisai Nov 11, 2020 09:00 JST Read More
LENVIMA Plus KEYTRUDA Demonstrated Statistically Significant Improvement in Progression-Free Survival, Overall Survival and Objective Response Rate Versus Sunitinib as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma Eisai Nov 11, 2020 08:56 HKT/SGT Read More
シスメックスとエーザイ、第13回アルツハイマー病臨床試験会議(CTAD)において血液による簡便なアルツハイマー病診断法の創出に向けた学術報告 Eisai Nov 09, 2020 10:00 JST Read More
Eisai: Sysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimer's Disease Using Blood Eisai Nov 09, 2020 08:08 HKT/SGT Read More
BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity BioVaxys Technology Corp. Nov 02, 2020 21:00 HKT/SGT Read More
Olympus announces acquisition of FH ORTHO, an international orthopedics company in France Olympus Nov 02, 2020 14:00 HKT/SGT Read More
Eisai to Present Latest Data on Pipeline Assets in the Area of Alzheimer's Disease and Dementia at the 13th Clinical Trials on Alzheimer's Disease Conference Eisai Oct 28, 2020 09:07 HKT/SGT Read More
エーザイ、第13回アルツハイマー病臨床試験会議(CTAD)においてアルツハイマー病/認知症領域の開発品に関する最新データを発表 Eisai Oct 28, 2020 09:00 JST Read More
Eisai and JD Health Establish JV Company in China to Implement Health Service Platform Eisai Oct 28, 2020 08:01 HKT/SGT Read More
Global Coalition for Adaptive Research・アムジェン・エーザイ、COVID-19グローバル試験に最初の患者様が登録されたことを発表 Eisai Oct 27, 2020 09:00 JST Read More
Eisai and Cogstate Expand Agreement for Global Development and Commercialization of Digital Cognitive Assessment Technologies Eisai Oct 26, 2020 15:52 HKT/SGT Read More
中国生物制药回购950万股股份及董事会资深副主席兼执行董事谢炳先生增持约600万股股份 Sino Biopharmaceutical Limited Oct 23, 2020 18:31 HKT/SGT Read More